Literature DB >> 21880525

Clinical risk factors for fracture in diabetes: a matched cohort analysis.

Lisa-Ann Fraser1, Janet Pritchard, George Ioannidis, Lora M Giangegorio, Jonathan D Adachi, Alexandra Papaioannou, William D Leslie.   

Abstract

The objective was to determine which individuals with diabetes are at increased risk for fracture. It is unknown whether traditional clinical risk factors (CRFs) can be used in this population to identify individuals at higher risk of fracture. Using the Manitoba Bone Density Program database, we identified 3054 diabetic women and 9151 matched nondiabetic controls. The independent association of specific CRFs with incident osteoporotic fracture risk was assessed separately in those with diabetes and in controls, with subsequent examination of the interaction between diagnosed diabetes and each CRF. Prior major fractures were more prevalent in the diabetic group compared with the nondiabetic group (16.2% vs 14.3%, p<0.001). During mean 4 yr of observation, 259 (8.5%) of diabetic women and 559 (6.5%) of nondiabetic women experienced an incident major osteoporotic fracture (unadjusted hazard ratio [HR] for diabetes 1.49 [95% confidence interval (CI): 1.28-1.72], p<0.001; adjusted HR 1.14 [95% CI: 1.10-1.18], p<0.001). There were no significant differences between the 2 groups in the HRs for incident fracture associated with any of the CRFs studied (all p-for-interaction >0.1). Diabetes is a risk factor for major fracture. The ability of traditional CRFs to predict osteoporotic fractures is not influenced by the diagnosis of diabetes. Copyright Â
© 2011 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21880525      PMCID: PMC5096921          DOI: 10.1016/j.jocd.2011.06.007

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  22 in total

1.  Normal bone density obtained in the absence of insulin receptor expression in bone.

Authors:  Regina Irwin; Hua V Lin; Katherine J Motyl; Laura R McCabe
Journal:  Endocrinology       Date:  2006-09-14       Impact factor: 4.736

2.  Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings.

Authors:  G Hein; C Weiss; G Lehmann; T Niwa; G Stein; S Franke
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

3.  Registries and administrative data: organization and accuracy.

Authors:  L L Roos; C A Mustard; J P Nicol; D F McLerran; D J Malenka; T K Young; M M Cohen
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

4.  Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.

Authors:  W D Leslie; L M Lix; L Langsetmo; C Berger; D Goltzman; D A Hanley; J D Adachi; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2010-12-16       Impact factor: 4.507

5.  Diabetes and risk of fracture: The Blue Mountains Eye Study.

Authors:  R Q Ivers; R G Cumming; P Mitchell; A J Peduto
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

6.  Weight change and diabetes incidence: findings from a national cohort of US adults.

Authors:  E S Ford; D F Williamson; S Liu
Journal:  Am J Epidemiol       Date:  1997-08-01       Impact factor: 4.897

7.  Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.

Authors:  I I de Liefde; M van der Klift; C E D H de Laet; P L A van Daele; A Hofman; H A P Pols
Journal:  Osteoporos Int       Date:  2005-06-07       Impact factor: 4.507

8.  Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes.

Authors:  Toru Yamaguchi; Ippei Kanazawa; Masahiro Yamamoto; Soichi Kurioka; Mika Yamauchi; Shozo Yano; Toshitsugu Sugimoto
Journal:  Bone       Date:  2009-05-13       Impact factor: 4.398

9.  Fracture risk in type 2 diabetes: update of a population-based study.

Authors:  L Joseph Melton; Cynthia L Leibson; Sara J Achenbach; Terry M Therneau; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

10.  Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

Authors:  Steven E Kahn; Bernard Zinman; John M Lachin; Steven M Haffner; William H Herman; Rury R Holman; Barbara G Kravitz; Dahong Yu; Mark A Heise; R Paul Aftring; Giancarlo Viberti
Journal:  Diabetes Care       Date:  2008-01-25       Impact factor: 19.112

View more
  5 in total

1.  Risk of low-energy fracture in type 2 diabetes patients: a meta-analysis of observational studies.

Authors:  P Jia; L Bao; H Chen; J Yuan; W Liu; F Feng; J Li; H Tang
Journal:  Osteoporos Int       Date:  2017-08-09       Impact factor: 4.507

2.  Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?

Authors:  W D Leslie; S N Morin; L M Lix; S R Majumdar
Journal:  Osteoporos Int       Date:  2014-08-05       Impact factor: 4.507

3.  OSTEOPOROSIS AND FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.

Authors:  C Poiana; C Capatina
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

Review 4.  Diagnosis and management of bone fragility in diabetes: an emerging challenge.

Authors:  S L Ferrari; B Abrahamsen; N Napoli; K Akesson; M Chandran; R Eastell; G El-Hajj Fuleihan; R Josse; D L Kendler; M Kraenzlin; A Suzuki; D D Pierroz; A V Schwartz; W D Leslie
Journal:  Osteoporos Int       Date:  2018-07-31       Impact factor: 4.507

5.  The association between risk of limb fracture and type 2 diabetes mellitus.

Authors:  Jie Liu; Lei Cao; Yao-Wen Qian; Zhi-Xin Chen; Shi-Fang Guo; Wei-Qiang Sun; Zong-Ru He
Journal:  Oncotarget       Date:  2018-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.